Details for New Drug Application (NDA): 070022
✉ Email this page to a colleague
NDA 070022 describes SULFAMETHOPRIM, which is a drug marketed by Novel Labs Inc and is included in two NDAs. Additional details are available on the SULFAMETHOPRIM profile page.
The generic ingredient in SULFAMETHOPRIM is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
The generic ingredient in SULFAMETHOPRIM is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
Summary for 070022
| Tradename: | SULFAMETHOPRIM |
| Applicant: | Novel Labs Inc |
| Ingredient: | sulfamethoxazole; trimethoprim |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 400MG;80MG | ||||
| Approval Date: | Feb 15, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
